Setting New Therapeutic Standards in Advanced HCC

Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitor combinations for patients with advanced hepatocellular carcinoma.
Richard S. Finn, MD
Amit G. Singal, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 3.61 MB
Released: November 12, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Related Content

In slides from Clinical Care Options (CCO), experts discuss emerging data surrounding use of immune checkpoint inhibitors for early HCC

Amit G. Singal, MD, MS Released: November 12, 2021

In slides from Clinical Care Options (CCO), experts provide insights on the use of targeted therapies for advanced biliary tract cancer

Mark Yarchoan, MD Released: November 12, 2021

From Clinical Care Options (CCO), download a PDF featuring expert answers to HCP questions on immunotherapy for patients with advanced HCC

Released: June 29, 2021

From Clinical Care Options (CCO), download a PDF featuring expert discussion of immunotherapy for case patients with advanced HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Released: May 17, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings